NIHR Biomedical Research Centres
Lilly and WHO Foundation partner to support global dementia action plan
The partnership will provide financial support and strengthen early detection and intervention efforts
Biogen expands portfolio in deal with Alcyone Therapeutics
The agreement gives Biogen full rights to a potential therapy for patients with neurological disorders
Lilly launches global Alzheimer’s campaign with Julianne Moore
The new ‘Brain Health Matters’ campaign urges the public to prioritise brain health
UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS
The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention
BioNTech announces £1bn UK investment to boost regional R&D presence
The UK government has also agreed to award the company a grant of up to £129m
UK government’s AMR study highlights importance of appropriate antibiotic use
The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam
GSK to explore link between Shingrix and dementia risk in new UK research collaboration
More than 55 million people worldwide are currently living with the neurodegenerative disease
Prime minister unveils UK government’s plans to abolish NHS England
The move aims to cut waiting times and free up money for front-line services
UK government launches ‘landmark’ AI breast cancer screening trial
Approximately 55,000 cases of the disease are diagnosed every year in the UK
UK drug repurposing study identifies several potential dementia treatments
An estimated 982,000 people in the UK are currently living with the neurodegenerative disease
UK study shows RSV vaccine could reduce antibiotic use and antimicrobial resistance
The new analysis found that RSV infections lead to 640,000 antibiotic prescriptions every year
Eli Lilly shares positive results for modified titration of Alzheimer’s drug donanemab
The neurodegenerative disorder accounts for up to 75% of the 982,000 dementia cases in the UK